Stephen E. Spurgeon
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 73
- Chronic Lymphocytic Leukemia Research 71
-
- Lymphoma Diagnosis and Treatment 47
- Co-authors
- Ian W. Flinn (17 shared papers)Richard R. Furman (19 shared papers)Jennifer R. Brown (15 shared papers)Steven Coutré (14 shared papers)Nina D. Wagner‐Johnston (14 shared papers)Brad S. Kahl (14 shared papers)Sissy Peterman (12 shared papers)Don M. Benson (10 shared papers)
- Journals
- Blood (35 papers)Journal of Clinical Oncology (15 papers)Oncotarget (4 papers)HemaSphere (3 papers)British Journal of Haematology (2 papers)
- Partner nations
- United StatesIndiaPoland
In The Last Decade
Stephen E. Spurgeon
92 papers receiving 2.5k citations
Stephen E. Spurgeon's Hit Papers
Peers
Comparison fields: 5 of 79
- Genetics 1.5k
- Pathology and Forensic Medicine 1.2k
- Hematology 498
- Oncology 629
- Immunology 500
Countries citing papers authored by Stephen E. Spurgeon
This map shows the geographic impact of Stephen E. Spurgeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Spurgeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Spurgeon more than expected).
Fields of papers citing papers by Stephen E. Spurgeon
This network shows the impact of papers produced by Stephen E. Spurgeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Spurgeon. The network helps show where Stephen E. Spurgeon may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen E. Spurgeon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia Hit paper breakdown → | 2014 | 479 |
| 2 | 2014 | 205 | |
| 3 | 2014 | 170 | |
| 4 | 2016 | 117 | |
| 5 | 2012 | 104 | |
| 6 | 2010 | 103 | |
| 7 | 2010 | 92 | |
| 8 | 2012 | 60 | |
| 9 | 2011 | 60 | |
| 10 | 2014 | 56 | |
| 11 | 2016 | 56 | |
| 12 | 2014 | 56 | |
| 13 | 2018 | 53 | |
| 14 | 2016 | 51 | |
| 15 | 2013 | 48 | |
| 16 | 2009 | 47 | |
| 17 | 2015 | 42 | |
| 18 | 2012 | 41 | |
| 19 | 2013 | 39 | |
| 20 | 2018 | 37 |
About Stephen E. Spurgeon
Stephen E. Spurgeon is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Molecular Biology and Hematology, having authored 99 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (71 papers), Lymphoma Diagnosis and Treatment (47 papers), Immunodeficiency and Autoimmune Disorders (14 papers), Viral-associated cancers and disorders (13 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), CAR-T cell therapy research (11 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Genetics (1.5k citations), Pathology and Forensic Medicine (1.2k citations), Hematology (498 citations), Oncology (629 citations) and Immunology (500 citations). Stephen E. Spurgeon has collaborated with scholars based in United States, India and Poland. Frequent co-authors include Ian W. Flinn, Richard R. Furman, Jennifer R. Brown, Steven Coutré, Nina D. Wagner‐Johnston, Brad S. Kahl, Sissy Peterman, Don M. Benson, Albert S. Yu and John C. Byrd. Their work appears in journals such as Blood, Journal of Clinical Oncology, Oncotarget, HemaSphere and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.